Non-canonical MAPK signaling in yeast
酵母中的非典型 MAPK 信号传导
基本信息
- 批准号:9332459
- 负责人:
- 金额:$ 31.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-08-15 至 2020-05-31
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseAnaphaseApoptosisBehaviorBindingBiological ModelsCell NucleusCell divisionCellsCellular StructuresComplexCongenital AbnormalityCuesDataDevelopmentDiseaseEnzymesFamilyGerm CellsHaploidyHealthHumanLocationMAPK14 geneMAPK8 geneMalignant NeoplasmsMeiosisMembraneMitogen-Activated Protein Kinase KinasesMitogen-Activated Protein KinasesMitogensModelingMolecularMolecular ConformationMorphogenesisOutputPathway interactionsPhosphorylationPhosphotransferasesPhysiologic pulsePropertyProtein KinaseProteinsPublishingRNARNA BindingRNA Recognition MotifReactionReproduction sporesRoleSaccharomyces cerevisiaeShapesSignal PathwaySignal TransductionSiteSpecificityStimulusStressSystemTestingThreonineTimeTranslatingTranslationsTyrosineYeastsbasecell growthcyclin-dependent kinase-activating kinasein vitro Assayinsightnovelprogramsreconstitutionspatiotemporalubiquitin-protein ligase
项目摘要
Project Summary/Abstract: Mitogen activated protein kinases (MAPKs) are key
signaling enzymes that are activated by phosphorylation of a TXY motif in their activation
loops. While dual-specificity MAPK kinases activate many MAPKs (canonical signaling),
atypical kinases and autophosphorylation can also activate MAPKs (non-canonical
signaling). A great deal is known about the role of canonical signaling pathways in health
and disease. Much less is known about non-canonical signaling. Smk1 is a meiosis-
specific MAPK in the yeast S. cerevisiae that controls gamete formation (sporulation)
through a non-canonical signaling pathway that generates different forms of the MAPK
at different stages of meiosis. First, the CDK activating kinase, Cak1, phosphorylates
Smk1's activating T-residue as the meiotic divisions are taking place. This
monophosphorylated form of Smk1 is distributed throughout the cell. Later in the
program (at anaphase II), a meiosis-specific protein, Ssp2, binds to Smk1 and activates
the cis-autophosphorylation of its Y-residue. This reaction occurs at specific
membraneous structures that cellularize the haploids generated in this specialized cell
division. Thus, Ssp2 delivers a pulse of the doubly phosphorylated MAPK to the “right
place” at the “right time” in this developmental program. This spatiotemporal specificity is
achieved by modularity of the Ssp2 protein; it is localized by a targeting domain (TD) and
it activates cis-autophosphorylation of the MAPK via a kinase activating domain (KAD).
The Ssp2KAD is itself composed of segments that bind Smk1 and a regulatory RNA
recognition motif (RRM). This proposal is to use the Ssp2KAD/Smk1 reaction as a model
to study autoactivation of MAPKs in the context of a developmental system. The specific
aims of this proposal are: 1- Elucidate molecular mechanisms of non-canonical MAPK
signaling using a bacterial reconstitution system and purified proteins, 2-Test a
competition-based switch-site model for Smk1 activation, and 3- Identify the RNA(s)
recognized by the RNA recognition motif in Ssp2.
项目概要/摘要:促分裂原活化蛋白激酶(MAPKs)是
在其活化过程中通过TXY基序的磷酸化而活化的信号传导酶
循环虽然双特异性MAPK激酶激活许多MAPK(典型信号传导),
非典型激酶和自身磷酸化也可以激活MAPK(非典型的
信令)。关于经典信号通路在健康中的作用,
和疾病对非规范信号的了解要少得多。Smk 1是一个减数分裂-
酵母S.控制配子形成(孢子形成)的酿酒酵母
通过一个非经典的信号通路产生不同形式的MAPK,
在减数分裂的不同阶段。首先,CDK激活激酶Cak 1磷酸化
当减数分裂发生时,Smk 1激活T残基。这
Smk 1的单磷酸化形式分布在整个细胞中。晚些
程序(在后期II),减数分裂特异性蛋白Ssp 2与Smk 1结合并激活
其Y残基的顺式自磷酸化。该反应发生在特定的
使这种特化细胞产生的单倍体细胞化的膜状结构
师.因此,Ssp 2将双重磷酸化的MAPK脉冲传递到“右侧”,
在这个发展计划中的“正确时间”。这种时空特异性
通过Ssp 2蛋白的模块化实现;它通过靶向结构域(TD)定位,
它通过激酶激活结构域(KAD)激活MAPK的顺式自磷酸化。
Ssp 2KAD本身由结合Smk 1和调节RNA的片段组成
识别基序(RRM)。本文以Ssp 2KAD/Smk 1反应为模型,
研究MAPKs在发育系统中的自激活。具体
本提案的目的是:1-阐明非经典MAPK的分子机制
使用细菌重建系统和纯化蛋白质的信号传导,2-测试a
Smk 1激活的基于竞争的开关位点模型,以及3-识别RNA
由Ssp 2中的RNA识别基序识别。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
EDWARD P WINTER其他文献
EDWARD P WINTER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('EDWARD P WINTER', 18)}}的其他基金
PROTEIN KINASE NETWORKS AND SPORULATION IN S. CEREVISIAE
酿酒酵母中的蛋白激酶网络和孢子形成
- 批准号:
7990577 - 财政年份:2009
- 资助金额:
$ 31.2万 - 项目类别:
PROTEIN KINASE NETWORKS AND SPORULATION IN S. CEREVISIAE
酿酒酵母中的蛋白激酶网络和孢子形成
- 批准号:
6900259 - 财政年份:2000
- 资助金额:
$ 31.2万 - 项目类别:
PROTEIN KINASE NETWORKS AND SPORULATION IN S. CEREVISIAE
酿酒酵母中的蛋白激酶网络和孢子形成
- 批准号:
7103651 - 财政年份:2000
- 资助金额:
$ 31.2万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 31.2万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 31.2万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 31.2万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 31.2万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 31.2万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 31.2万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 31.2万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 31.2万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 31.2万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 31.2万 - 项目类别: